A pooled analysis of five prospective trials showed that stereotactic body radiotherapy (SBRT) was associated with a lower risk for biochemical failure over 10 years vs high-dose rate brachytherapy ...
HDR-BT was significantly associated with increased biochemical failure risk and acute grade 2 or higher genitourinary adverse events. In men with intermediate-risk prostate cancer, stereotactic body ...
Brussels, 17 July 2025 – Today marks Brachytherapy Awareness Day, a global initiative to spotlight a cancer treatment that is saving lives with precision: brachytherapy. This advanced form of internal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results